Assoc. Prof. Dr. Peng Yu - Endocrinology and Metabolism - Best Researcher Award

The Second Affiliated Hospital of Nanchang University - China 

Author Profile 

SCOPUS 

ORCID 

🎓 Early academic pursuits

Peng Yu began his academic journey with a strong inclination toward clinical medicine and biomedical sciences. his early interests laid a solid foundation for his future in endocrinology and metabolic disorders. throughout his training, he consistently demonstrated a deep understanding of clinical diagnostics and research, eventually earning recognition that propelled him toward advanced roles in both clinical practice and academic instruction.

🩺 Professional endeavors

Currently serving as associate chief physician at the second affiliated hospital of nanchang university, peng yu also holds the titles of associate professor and master’s supervisor. he is actively engaged in shaping the next generation of medical professionals. beyond his institutional commitments, he contributes nationally and internationally as a young committee member of the cardiovascular metabolic alliance, vice chair of the youth committee of the jiangxi diabetes society, and a young member of the asia pacific heart rhythm society (aphrs). while primarily rooted in medical science, his interdisciplinary work intersects with power electronics, especially in metabolic monitoring and biomedical device development.

🔬 Contributions and research focus

Peng Yu has authored over 170 research papers, with more than 100 indexed in sci journals, accumulating a total impact factor exceeding 400. notably, he is the first or corresponding Endocrinology and Metabolism author of over 60 sci articles, contributing to high-impact publications such as nature communications, aging and disease, and iubmb life. his research centers on endocrinology, diabetes, metabolism, and cardiovascular disorders, often exploring the synergy between genetics, aging, and metabolic health. he has notably collaborated with international leaders to merge insights from power electronics, genetics, and clinical endocrinology to enhance non-invasive diagnostic approaches.

🌐 Impact and influence

Peng Yu's innovative research has not only attracted over 2,000 academic citations but also informed global practices, including incorporation into the european society of cardiology guidelines. his collaborations with professors zhixiang xu (uab) and zhongcong xie (harvard/mgh) have enhanced cross-border scientific exchange. his influence extends to journal editorial Endocrinology and Metabolism duties, where he reviews for more than 20 prestigious sci journals, reinforcing scholarly quality across various disciplines. his translational research benefits from technology embedded in power electronics, especially for health monitoring systems.

📚 Academic cites and recognitions

You can view his scopus citation index here, where his extensive academic footprint showcases the depth and consistency of his contributions. many of his works serve as references for further Endocrinology and Metabolism innovations in both medical research and clinical protocols, especially in fields linked with metabolism and biomedical engineering.

🧠 Legacy and future contributions

with over 60 research projects under his belt and 20 led personally as principal investigator—securing around ¥4 million in funding—peng yu is poised for continued impact. he has filed 100+ patents, with 60 granted, including two invention patents, further underscoring his commitment to practical medical innovation. as he looks forward, his focus lies in integrating clinical endocrinology with precision diagnostics, artificial intelligence, and applications inspired by power electronics, creating smarter, patient-centered medical solutions.

Notable Publications 

  • Title: Non-Vitamin K Antagonist Oral Anticoagulants in Secondary Stroke Prevention in Atrial Fibrillation Patients: An Updated Analysis by Adding Observational Studies
    Author(s): Yu Peng
    Journal: Cardiovascular Drugs and Therapy

  • Title: Comparison of HAS-BLED with other risk models for predicting the bleeding risk in anticoagulated patients with atrial fibrillation
    Author(s): Yu Peng
    Journal: Medicine

  • Title: Dose-response relationship of cardiorespiratory fitness with incident atrial fibrillation
    Author(s): Yu Peng
    Journal: Heart Failure Reviews

  • Title: Effect of non-vitamin K antagonist oral anticoagulants versus warfarin in heart failure patients with atrial fibrillation
    Author(s): Yu Peng
    Journal: Heart Failure Reviews

  • Title: Dose-response analysis between hemoglobin A1c and risk of atrial fibrillation in patients with and without known diabetes
    Author(s): Yu Peng
    Journal: PLOS ONE

Assoc. Prof. Dr. Peng Yu – Endocrinology and Metabolism – Best Researcher Award